Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 26, Issue 5-6, Pages 209-216
http://dx.doi.org/10.3233/DMA-2009-0636

Lipid Measures and Cardiovascular Disease Prediction

Diederik F. van Wijk, Erik S. G. Stroes, and John J. P. Kastelein

Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands

Received 15 September 2009; Accepted 15 September 2009

Copyright © 2009 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Traditional lipid measures are the cornerstone of risk assessment and treatment goals in cardiovascular prevention. Whereas the association between total, LDL-, HDL-cholesterol and cardiovascular disease risk has been generally acknowledged, the rather poor capacity to distinguish between patients who will and those who will not develop cardiovascular disease has prompted the search for further refinement of these traditional measures. A thorough understanding of lipid metabolism is mandatory to understand recent developments in this area. After a brief overview of lipid metabolism we will discuss the epidemiological data of total, LDL- and HDL-cholesterol and focus on recent advances in measurements of these lipoproteins. In addition we will discuss the role of triglycerides and the apolipoprotein B–A-I ratio on the incidence of cardiovascular disease.